Mr. Kenneth Lee
Independent Director
Sinovac
Sinovac Biotech
China
Biography
Mr. Kenneth Lee is an independent director of Sinovac. He served on the Company’s Board of Directors since May 2011. In July 2012, the Board appointed him to the Compensation Committee and Corporate Governance and Nominating Committee as an independent director. Mr. Lee is a partner at SAIF Partners. SAIF Partners IV L.P. is currently the largest shareholder in Sinovac. Mr. Lee has close to 20 years of experience across private equity investment, corporate finance, and business development in China. Before joining SAIF in 2007, he had served as the chief financial officer of Topsec Holdings from 2006 to 2007. From 2004 to 2005, he worked as a principal at RimAsia Capital Partners. Prior to RimAsia Capital Partners, Mr. Lee served in various positions at Delta Associates, the exclusive advisor to Asia Equity Infrastructure Fund,CNK Telecommunications Limited, H&Q Asia Pacific and Salomon Brothers Inc. in New York. Currently, he is a non-executive director on the boards of four Chinese portfolio companies publicly listed on the stock exchanges in USA and Hong Kong and a board director for four other private Chinese companies backed by SAIF Partners. Mr. Lee is a graduate of Amherst College.
Research Interest
Molecular Biology and Molecular Genetics